Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,855 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
Regulatory Filings
2026-05-07 English
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
Regulatory Filings
2026-05-07 English
6-K - GALAPAGOS NV (0001421876) (Filer)
Foreign Filer Report
2026-05-06 English
6-K - GALAPAGOS NV (0001421876) (Filer)
Foreign Filer Report
2026-04-29 English
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release announcing that all proposals at the Ordinary and Extraordinary General Meetings on 28 April 2026 were approved, listing each approved resolution (e.g., approval of the annual report, board appointments, share buyback authorisation, name change). This is a declaration of shareholder voting results at general meetings, matching the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-04-29 Dutch
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is an announcement from Galápagos summarizing the resolutions approved at its Annual and Extraordinary Shareholders’ Meetings held on 28 April 2026. It lists the items approved by shareholders (e.g., approval of the Annual Report and Remuneration Report, board appointments, name change, share acquisition authorization, capital renewal) and states that meeting minutes will follow. This is clearly a declaration of voting results from the shareholder meetings, matching the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-04-29 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.